UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Catalogue
Articles
RSS feedX
Search Filters
Format
Subjects
Language
Publication DateJournal of hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 1, pp. 155 - 168
Gastroenterology and Hepatology | Gallstones | Liver cancer | Bile acids | Fatty liver disease | Cholestasis | Liver regeneration | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Animals | Carrier Proteins - metabolism | Cholestasis - metabolism | Membrane Glycoproteins - metabolism | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Liver Diseases - metabolism | Liver Regeneration - physiology | Receptors, Cytoplasmic and Nuclear - metabolism | Drug resistance in microorganisms | Corticosteroids | Glucagon | Calcifediol | Ursodiol | Deoxycholic acid | Epidermal growth factor | Vitamin D | Physiological aspects | Fibroblast growth factors | Alfacalcidol | Index Medicus | IBABP (FABP6, ILBP), intestinal bile acid-binding protein, fatty acid-binding protein 6 | PFIC, progressive familial intrahepatic cholestasis | TNFα, tumor necrosis factor α | 3 (human) | SRC2, p160 steroid receptor coactivator | NAFLD, non-alcoholic fatty liver disease | BA, bile acid | bile acid receptor | 8, cholesterol efflux pump, ATP-binding cassette, subfamily G, member 5 | UDCA, ursodeoxycholic acid | LRH-1 (NR5A2), liver receptor homolog-1 | LCA, lithocholic acid | LXRα (NR1H3), liver X receptor alpha | PPARγ (NR1C3), peroxisome proliferator-activated receptor gamma | OSTαβ, organic solute transporter alpha | ABCG5 | AMPK, AMP activated protein kinase | NASH, non-alcoholic steatohepatitis | SHP (NR0B2), short heterodimer partner | OATP1A2 (SLCO1A2, OATP1, OATP-A, SLC21A3), solute carrier organic anion transporter family, member 1A2 | EGFR, epidermal growth factor receptor | IL6, interleukin 6 | TGR5, G protein-coupled bile acid receptor | PH, partial hepatectomy | AE2, anion exchanger 2 | PSC, primary sclerosing cholangitis | OATP1B1 (SLCO1B1, OATP2, OATP-C, SLC21A6), solute carrier organic anion transporter family, member 1B1 | RARα (NR1B1), retinoic acid receptor alpha | GLP-1, glucagon like peptide 1 | VDR (NR1I1), vitamin D receptor. Please note that for the convenience of better readability and clarity, abbreviations for transporters and nuclear receptors were capitalized throughout this article when symbols were identical for human and rodents | MRP2 (ABCC2), multidrug resistance-associated protein 2, ATP-binding cassette, subfamily C, member 2 | NTCP (SLC10A1), sodium | CAR (NR1I3), constitutive androstane receptor | taurocholate cotransporting polypeptide, solute carrier family 10, member 1 | PPARα (NR1C1), peroxisome proliferator-activated receptor alpha | Review | GR (NR3C1), glucocorticoid receptor | Bile acids, Cholestasis, Fatty liver disease, Gallstones, Liver regeneration, Liver cancer | 19, fibroblast growth factor 15 | Mdr2 | ICP, intrahepatic cholestasis of pregnancy | BRIC, benign recurrent intrahepatic cholestasis | OATP1B3 (SLCO1B3, OATP8, SLC21A8), solute carrier organic anion transporter family, member 1B3 | MRP3 (ABCC3), multidrug resistance-associated protein 3, ATP-binding cassette, subfamily C, member 3 | beta | MDR1 (ABCB1), p-glycoprotein, ATP-binding cassette, subfamily B, member 1 | norUDCA, norursodeoxycholic acid | 6-ECDCA, 6-ethylchenodeoxycholic acid | FXR (NR1H4), farnesoid X receptor | BCRP (ABCG2), breast cancer resistance protein, ATP-binding cassette, subfamily G, member 2 | HNF4α (NR2A1), hepatocyte nuclear factor 4 alpha | PBC, primary biliary cirrhosis | MDR3 (ABCB4), multidrug resistance protein 2 (rodents) | HNF1α, hepatocyte nuclear factor 1 alpha | NR, nuclear receptor | FGF15 | RXRα (NR2B1), retinoid X receptor alpha | PXR (NR1I2), pregnane X receptor | BSEP (ABCB11), bile salt export pump | HCC, hepatocellular carcinoma | MRP4 (ABCC4), multidrug resistance-associated protein 4, ATP-binding cassette, subfamily C, member 4 | TPN, total parenteral nutrition
Journal Article
Details 
Digital rights
Loading RightsJournal of hepatology, ISSN 0168-8278, 2012, Volume 56, Issue 5, pp. 1152 - 1158
Gastroenterology and Hepatology | Gallstones | Liver cancer | Bile acids | Fatty liver disease | Cholestasis | Liver regeneration | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Obesity | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Biological and medical sciences | Metabolic diseases | Medical sciences | Other diseases. Semiology | Tumors | Inflammation - pathology | Liver - pathology | Macrophages - pathology | Biopsy | Humans | Middle Aged | Fibrosis | Adult | Female | Male | Subcutaneous Fat - pathology | Obesity, Morbid - pathology | Adipose tissues | Liver diseases | Liver | Macrophage colony stimulating factor | Histochemistry | Index Medicus
Journal Article
Details
Digital rights
Loading RightsNuclear receptor signaling, ISSN 1550-7629, 2010, Volume 8, Issue 1, pp. e005 - e005
Cholestasis - metabolism | Bile Acids and Salts - chemistry | Receptors, Cytoplasmic and Nuclear - biosynthesis | Receptors, Cytoplasmic and Nuclear - chemistry | Cholestasis - drug therapy | Gallstones - metabolism | Liver Regeneration | Transcription Factors - physiology | Atherosclerosis - drug therapy | Gene Expression Regulation - genetics | Hyperlipidemias - drug therapy | Diabetes Mellitus - drug therapy | Liver Neoplasms - drug therapy | Receptors, Cytoplasmic and Nuclear - therapeutic use | Intestinal Diseases - drug therapy | Rats | Bile Acids and Salts - metabolism | Receptors, Cytoplasmic and Nuclear - genetics | Transcription Factors - genetics | Intestinal Diseases - metabolism | Triglycerides - metabolism | Transcription Factors - metabolism | Animals | Bile Acids and Salts - genetics | Gastrointestinal Stromal Tumors - drug therapy | Liver Neoplasms - metabolism | Glucose - metabolism | Gastrointestinal Stromal Tumors - metabolism | Gallstones - drug therapy | Receptors, Cytoplasmic and Nuclear - metabolism | Index Medicus
Journal Article
Details
Digital rights
Loading RightsHepatology (Baltimore, Md.), ISSN 0270-9139, 03/2011, Volume 53, Issue 3, pp. 1023 - 1034
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Biological and medical sciences | Medical sciences | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Carcinoma, Hepatocellular - physiopathology | Fatty Liver - metabolism | Cholesterol, HDL - metabolism | Fatty Liver - physiopathology | Humans | Liver - metabolism | Receptors, Cytoplasmic and Nuclear - therapeutic use | Lipid Metabolism | Receptors, Cytoplasmic and Nuclear - physiology | Chemical and Drug Induced Liver Injury - physiopathology | Liver Regeneration - physiology | Cholestasis - physiopathology | Triglycerides - metabolism | Hepatitis B - physiopathology | Transcription, Genetic - physiology | Hepatitis - physiopathology | Non-alcoholic Fatty Liver Disease | Glucose - metabolism | Hepatitis C - physiopathology | Bile Acids and Salts - physiology | Liver Cirrhosis - physiopathology | Liver Diseases - physiopathology | Liver | Liver diseases | Bile | Index Medicus
Journal Article
Details
Digital rights
Loading RightsInternational journal of molecular sciences, ISSN 1661-6596, 2012, Volume 13, Issue 7, pp. 8882 - 8914
Primary biliary cirrhosis | PSC | Vanishing bile duct syndrome | Side effects | Neonatal cholestasis | Toxicity | Extrahepatic biliary atresia | Neonatal hepatitis | Primary sclerosing cholangitis | Ursodeoxycholic acid | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Carcinoma, Hepatocellular - chemically induced | DNA Repair - drug effects | Humans | Liver Cirrhosis, Biliary - drug therapy | Tumor Suppressor Protein p53 - metabolism | Liver Neoplasms - chemically induced | Ursodeoxycholic Acid - adverse effects | Cholagogues and Choleretics - adverse effects | Liver Cirrhosis, Biliary - pathology | Coenzyme A - metabolism | Cholagogues and Choleretics - therapeutic use | Ursodeoxycholic Acid - therapeutic use | Animals | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | Liver Neoplasms - pathology | Cyclic AMP - metabolism | Liver Cirrhosis, Biliary - metabolism | Carcinoma, Hepatocellular - metabolism | Liver Regeneration - drug effects | Index Medicus | toxicity | vanishing bile duct syndrome | ursodeoxycholic acid | primary biliary cirrhosis | neonatal cholestasis | side effects | extrahepatic biliary atresia | neonatal hepatitis | primary sclerosing cholangitis
Journal Article
Details
Digital rights
Loading RightsClinics in liver disease, ISSN 1089-3261, 05/2013, Volume 17, Issue 2, pp. 161 - 189
Bile acids | Cholestatic liver disease | Nuclear receptors | Cholestasis | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Cholestasis - genetics | Bile Acids and Salts - biosynthesis | Receptors, Steroid - metabolism | Cholestasis - metabolism | Humans | Receptors, Cytoplasmic and Nuclear - agonists | Receptors, Cytoplasmic and Nuclear - genetics | Receptors, Glucocorticoid - metabolism | Signal Transduction - genetics | Receptors, Calcitriol - metabolism | Receptors, Calcitriol - genetics | Cholagogues and Choleretics - therapeutic use | Ursodeoxycholic Acid - therapeutic use | Animals | Receptors, Steroid - genetics | Signal Transduction - drug effects | Peroxisome Proliferator-Activated Receptors - metabolism | Ligands | Cholestasis - drug therapy | Homeostasis - drug effects | Receptors, Cytoplasmic and Nuclear - metabolism | Index Medicus
Journal Article
Details
Digital rights
Loading Rights